Breast cancer: a molecularly heterogenous disease needing subtype-specific treatments
U Testa, G Castelli, E Pelosi - Medical Sciences, 2020 - mdpi.com
Breast cancer is the most commonly occurring cancer in women. There were over two-
million new cases in world in 2018. It is the second leading cause of death from cancer in …
million new cases in world in 2018. It is the second leading cause of death from cancer in …
Breast cancer in the era of precision medicine
N Sarhangi, S Hajjari, SF Heydari, M Ganjizadeh… - Molecular Biology …, 2022 - Springer
Breast cancer is a heterogeneous disorder with different molecular subtypes and biological
characteristics for which there are diverse therapeutic approaches and clinical outcomes …
characteristics for which there are diverse therapeutic approaches and clinical outcomes …
Breast cancer: an up‐to‐date review and future perspectives
R Hong, B Xu - Cancer communications, 2022 - Wiley Online Library
Breast cancer is the most common cancer worldwide. The occurrence of breast cancer is
associated with many risk factors, including genetic and hereditary predisposition. Breast …
associated with many risk factors, including genetic and hereditary predisposition. Breast …
Extensive review on breast cancer its etiology, progression, prognostic markers, and treatment
H Swaminathan, K Saravanamurali, SA Yadav - Medical Oncology, 2023 - Springer
As the most frequent and vulnerable malignancy among women, breast cancer universally
manifests a formidable healthcare challenge. From a biological and molecular perspective, it …
manifests a formidable healthcare challenge. From a biological and molecular perspective, it …
[HTML][HTML] Clinical and molecular aspects of breast cancer: Targets and therapies
RLN Godone, GM Leitão, NB Araújo… - Biomedicine & …, 2018 - Elsevier
Breast Cancer is a complex disease characterized by the occurrence of multiple molecular
alterations. Currently, some molecular markers are in use for breast cancer diagnostic …
alterations. Currently, some molecular markers are in use for breast cancer diagnostic …
Breast cancer
N Harbeck, F Penault-Llorca… - Nature reviews …, 2019 - mayoclinic.elsevierpure.com
Breast cancer is the most frequent malignancy in women worldwide and is curable in~ 70–
80% of patients with early-stage, non-metastatic disease. Advanced breast cancer with …
80% of patients with early-stage, non-metastatic disease. Advanced breast cancer with …
Personalized therapy for breast cancer
FB De Abreu, GN Schwartz, WA Wells… - Clinical …, 2014 - Wiley Online Library
Breast cancer is a complex disease characterized by many morphological, clinical and
molecular features. For many years, this disease has been classified according to …
molecular features. For many years, this disease has been classified according to …
The crossroads of breast cancer progression: insights into the modulation of major signaling pathways
FJ Velloso, AFR Bianco, JO Farias… - OncoTargets and …, 2017 - Taylor & Francis
Cancer is the disease with highest public health impact in developed countries. Particularly,
breast cancer has the highest incidence in women worldwide and the fifth highest mortality …
breast cancer has the highest incidence in women worldwide and the fifth highest mortality …
Targeted therapies in breast cancer: where are we now?
S Di Cosimo, J Baselga - European Journal of Cancer, 2008 - Elsevier
Over the past several years significant advances have been made in our understanding of a
growing number of critical pathways involved in breast cancer. These advances have led to …
growing number of critical pathways involved in breast cancer. These advances have led to …
Histological and molecular classification of breast cancer: what do we know?
RG do Nascimento, KM Otoni - Mastology, 2020 - revistamastology.emnuvens.com.br
Breast cancer is the neoplasm most diagnosed malignancy and the leading cause of
mortality among women on a global scale. A profound increase in the understanding and …
mortality among women on a global scale. A profound increase in the understanding and …